Fundraising Fox
Eton Pharmaceuticals
NASDAQ: ETONSan Diego, US · Founded 2017 · Delaware corporation · 59 employees on LinkedIn
Find your way into Eton Pharmaceuticals
303 people in our graph share verified history with the Eton Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.
Joe Maseunlockedknows Sean Brynjelsen · together at Sagent Pharmaceuticals (overlapped)
knows the team · via Eton Pharmaceuticals
×4knows the team · via Horizon
knows the team · via Fisher College of Business
×4knows the team · via Orta Doğu Teknik Üniversitesi / Middle East Technical University
knows the team · via Akorn
Eton Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products, including injectable and rare disease treatments. Its leadership team has experience across pharmaceutical product development, commercialization, quality/GxP compliance, and finance.
Founders & leadership
Eton Pharmaceuticals was founded in 2017 by Sean Brynjelsen.
SB
Sean BrynjelsenFounder · CEOSean Brynjelsen is an executive at Eton Pharmaceuticals with background in pharmaceutical R&D, FDA matters, medical devices, and life sciences, and holds a degree from the University of Notre Dame's Mendoza College of Business.
SE
Sean E. BrynjelsenCEOSean E. Brynjelsen is President and CEO of Eton Pharmaceuticals, a specialty pharmaceutical company developing injectable and rare disease treatments. He holds a degree from the University of Notre Dame's Mendoza College of Business and has experience in pharmaceutical R&D, FDA regulatory affairs, medical devices, and oncology.
JR
James R. GruberChief Financial Officer2022–2026James R. Gruber is Chief Financial Officer, Treasurer, and Secretary at Eton Pharmaceuticals. He brings over 25 years of life sciences finance experience, including leadership roles managing financial organizations and capital allocation across healthcare, manufacturing, and distribution sectors, with an MBA from Northwestern University's Kellogg School of Management and a B.S. in Accounting from Indiana University.
IE
Ipek Erdogan-TrinkausChief Commercial Officer (CCO)Ipek Erdogan-Trinkaus has held commercial and leadership roles across pharmaceutical and nutrition companies, ranging from Fortune 100 organizations to startups, with expertise in brand building, strategy development, and team leadership.
MB
AB
Andrew BollNamed on SEC filing
Board
CC
Charles CasamentoBoard director
Reported raises · per SEC filings
Form D private placements$27.6M disclosed across 2 rounds · 2017–2020
▶$7.5MraisedApr 2020 · 2 investors · PharmaceuticalsRule 506(b)
▶$7.5MraisedApr 2020 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Mark L BaumDirector
- William Wilson TroutmanExecutive Officer
- Sean BrynjelsenExecutive Officer, Director
- Charles J CasamentoDirector
- Paul V MaierDirector
- Norbert G RiedelDirector
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$20.1MraisedJun 2017 · 230 investors · PharmaceuticalsRule 506(b)
▶$20.1MraisedJun 2017 · 230 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Charles CasamentoDirector
- Mark BaumDirector
- Andrew BollDirector
- Sean BrynjelsenExecutive Officer, Director
- Offering amount
- $20.1M
- Amount sold
- $20.1M
- Sales commissions
- $2M
- Placement agents
- National Securities Corporation
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$101.5Mvaluation at IPONov 2018 · $6.00/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
2 people who came through Eton Pharmaceuticals went on to found or lead other companies.
Competitors · 3
by search overlapWalgreens36 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Medscape19 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Simply Wall St18 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Companies competing with Eton Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Eton Pharmaceuticals do?
- Eton Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products, including injectable and rare disease treatments. Its leadership team has experience across pharmaceutical product development, commercialization, quality/GxP compliance, and finance.
- Who founded Eton Pharmaceuticals?
- Eton Pharmaceuticals was founded by Sean Brynjelsen in 2017.
- How much funding has Eton Pharmaceuticals raised?
- Eton Pharmaceuticals has disclosed $27.6M raised across 2 rounds.
- Where is Eton Pharmaceuticals headquartered?
- Eton Pharmaceuticals is headquartered in San Diego, US.